vebreltinib (APL-101) - Apollomics
Focus V (anlotinib) - Advenchen
https://asn.currinda2.com/website/events/6/days/2026-06-29/abstract/722
 
Xing-Fei Chen 1; Ying-Xi Chen 1; Guo-Ping Shen 1; Shun Yao 1; Li-Bin Huang 1; Yan-Lai Tang 1
 
Jun 30, 2026
 
Prev Next